The archived webinar is now available. Click here to view webinar recording. CEU's are now closed. The West Virginia Perinatal Partnership and West Virginia Immunization Network were pleased to co-host this webinar for healthcare providers and public health professionals in West Virginia on COVID-19 vaccination for people who are pregnant or breastfeeding. Pregnant people with […]
Click here to view the archived webinar. The presenters for this webinar will provide an overview of the risks of COVID-19 disease for pediatric populations and detail the available COVID-19 vaccination options for various age groups under age 18. The presenters will also provide evidence-based recommendations from the body of academic literature and qualitive and […]
Click here to view archived webinar. CE information is available below. Recently, the CDC recommended Moderna COVID-19 vaccine for children ages 6 months through 5 years and Pfizer-BioNTech vaccine for children ages 6 months through 4 years. This webinar will provide an overview of clinical presentation & overall impact of COVID-19 on children 6 months […]
Click here to view the webinar recording. The CDC recently recommended new booster shots targeted at the Omicron BA.4/BA.5 strains of SARS-CoV-2. This webinar will provide a situational update of the COVID-19 pandemic, the SARS COV-2 variants that are currently circulating, and the West Virginia response. It will also provide an overview of the recommendations […]
Click here to view the webinar recording. On Wednesday, October 12, 2022, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo expanding the use of updated (bivalent) COVID-19 vaccines to children ages 5 through 11 years. This follows the Food and Drug Administration’s (FDA) authorization of updated COVID-19 vaccines from Pfizer-BioNTech for children ages 5 through […]
Click here to view the archived webinar. CEUs are no longer available for this event. On Dec. 8, 2022, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the updated (bivalent) Moderna and Pfizer-BioNTech COVID-19 Omicron vaccines to include use in children down to 6 months of age. Following the EUA, the […]
Click here to view the archived webinar. On April 18, 2023, the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines were amended to simplify the vaccination schedule for most individuals. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to […]